New Approaches to Fetal Growth Restriction: The Time for Metabolomics Has Come

Area of Science:

• Reproductive biology
• Metabolomics
• Prenatal diagnostics

Background:

• Fetal growth restriction (FGR) is typically diagnosed postnatally using birth weight, missing opportunities for early intervention.
• Current diagnostic methods like ultrasound and Doppler have limitations in accurately assessing intrauterine development.
• FGR is linked to significant risks including neurodevelopmental delay and metabolic syndrome.

Purpose of the Study:

• To explore metabolomics as a novel approach for identifying biomarkers of intrauterine fetal development.
• To investigate the role of specific metabolites in fetal growth and weight.
• To advance the translational capacity of metabolomics for FGR diagnosis and management.

Main Methods:

• Review of recent evidence on metabolites associated with fetal growth and weight.
• Analysis of lipids (fatty acids), amino acids, vitamin D, and folic acid.
• Discussion of the need for standardized outcome sets in FGR research.

Main Results:

• Lipids, amino acids, vitamin D, and folic acid consistently play a role in fetal growth and weight.
• Metabolomics shows potential for identifying novel biomarkers for intrauterine development.
• Further research is needed to evaluate fetal energy metabolism and nervous system function across diverse populations.

Conclusions:

• Metabolomics holds promise for improving early FGR diagnosis and understanding its developmental impact.
• Establishing a core set of outcomes will enhance the identification of metabolite roles in FGR.
• Translational application of metabolomics can significantly advance FGR care.